Biothera names China distributor for Wellmune WGP
“Shanghai Toong Yeuan specialises in the sale of proprietary ingredients that are backed by credible science,” said Richard Mueller, Biothera’s CEO. “This focus, along with their well-established relationships with major food, beverage and supplement companies in China, makes Shanghai Toong Yeuan an excellent representative for Wellmune in this important market.”
David Wang, Shanghai Toong Yeuan’s chairman, said he believed Wellmune held significant potential in the China market.
The company has marked the partnership by sponsoring a seminar at Food Ingredients China from March 26, during which John Blocher, Biothera’s assistant vice-president for research and development, will discuss science of Wellmune WGP and present clinical research results with this unique ingredient.
